Changing Epidemiology of Cirrhosis and Hepatic Encephalopathy is a research paper published in Clinical Gastroenterology and Hepatology (2022). On theSindex it has a DataRank of 0.621. It has been cited 62 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.621
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →American Association for the Study of Liver Diseases
Grant: T32DK007634
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: 1K23DK117055
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: U01DK130113
NIDDK NIH HHS
Grant: K23 DK117055
National Institutes of Health
Grant: 1K23DK117055-01A1
Optimizing Measures for Clinical Trials in Covert Hepatic Encephalopathy
National Institutes of Health
Grant: 5U01DK130113-03
Statin Therapy for patients with compensated Cirrhosis
Allergan
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5T32DK007634-21
Digestive Disease Epidemiology Training Program
National Institutes of Health
Novo Nordisk
Allergan
Valeant Pharmaceuticals International
Gilead Sciences
FWCI
6.87
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals